Patrick Johnston
Mayo Clinic · Associate Professor of Medicine, College of Medicine, Mayo Clinic, Rochester, USA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patrick Johnston as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:58 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02254239 · Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin LymphomaMayo Clinic · terminated · Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma · principal investigator
- Ph1NCT01334502 · Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaAlliance for Clinical Trials in Oncology · completed · Lymphoma · study chair
- Ph2NCT01261247 · Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo Clinic · completed · Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma · study chair
- Ph2NCT00843050 · A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell LymphomaPiramal Enterprises Limited · terminated · Mantle Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Pathology Research Shared ResourceP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI THOMAS J FLOTTE · fiscal years 2011 to 2026Named on NCT02254239
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:58 UTC. The ranking covers the 200 most relevant of 117 PubMed records, and a shared surname and initials can bring in a namesake. All 117 on PubMed
- 1,091 citationsRCR 31.0
- 954 citationsRCR 29.2
- 717 citationsRCR 47.4
- 678 citationsRCR 30.5
- 620 citationsRCR 13.2
- Temporal processing deficits of language-learning impaired children ameliorated by training.Science · 1996548 citationsRCR 19.0
- The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.J Clin Oncol · 1994397 citationsRCR 11.7
- 387 citationsRCR 12.1
- Simvastatin in the acute respiratory distress syndrome.N Engl J Med · 2014383 citationsRCR 12.3
- 379 citationsRCR 33.6